Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

MD BIO : revenue, balance sheet and financial ratios

MD BIO is a French company founded 4 years ago, specialized in the sector Supérettes. Based in CHARMEIL (03110), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MD BIO (SIREN 908939465)
Indicator 2023
Revenue N/C
Net income 0 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2023, MD BIO records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 72%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

71.828%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

23.627%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

81.5%

Solvency indicators evolution
MD BIO

Sector positioning

Debt ratio
71.83 2023
2023
Q1: 0.25
Med: 28.55
Q3: 98.94
Average

In 2023, the debt ratio of MD BIO (71.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
23.63% 2023
2023
Q1: 9.88%
Med: 33.66%
Q3: 52.58%
Average

In 2023, the financial autonomy of MD BIO (23.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 229.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

229.579

Liquidity indicators evolution
MD BIO

Sector positioning

Liquidity ratio
229.58 2023
2023
Q1: 99.14
Med: 149.39
Q3: 229.31
Excellent

In 2023, the liquidity ratio of MD BIO (229.58) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of MD BIO in its sector

Comparison with sector Supérettes

Similar companies (Supérettes)

Compare MD BIO with other companies in the same sector:

Frequently asked questions about MD BIO

What is the revenue of MD BIO ?

The revenue of MD BIO is not publicly disclosed (confidential accounts filed with INPI).

Is MD BIO profitable?

Profitability information is not publicly available.

Where is the headquarters of MD BIO ?

The headquarters of MD BIO is located in CHARMEIL (03110), in the department Allier.

Where to find the tax return of MD BIO ?

The tax return of MD BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MD BIO operate?

MD BIO operates in the sector Supérettes (NAF code 47.11C). See the 'Sector positioning' section above to compare the company with its competitors.